Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative Multicentric Evaluation of Inter-Observer Variability in Manual and Automatic Segmentation of Neuroblastic Tumors in Magnetic Resonance Images.
Veiga-Canuto D, Cerdà-Alberich L, Sangüesa Nebot C, Martínez de Las Heras B, Pötschger U, Gabelloni M, Carot Sierra JM, Taschner-Mandl S, Düster V, Cañete A, Ladenstein R, Neri E, Martí-Bonmatí L. Veiga-Canuto D, et al. Among authors: canete a. Cancers (Basel). 2022 Jul 27;14(15):3648. doi: 10.3390/cancers14153648. Cancers (Basel). 2022. PMID: 35954314 Free PMC article.
Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study.
Morini M, Cangelosi D, Segalerba D, Marimpietri D, Raggi F, Castellano A, Fruci D, de Mora JF, Cañete A, Yáñez Y, Viprey V, Corrias MV, Carlini B, Pezzolo A, Schleiermacher G, Mazzocco K, Ladenstein R, Sementa AR, Conte M, Garaventa A, Burchill S, Luksch R, Bosco MC, Eva A, Varesio L. Morini M, et al. Among authors: canete a. Cancers (Basel). 2019 Sep 30;11(10):1476. doi: 10.3390/cancers11101476. Cancers (Basel). 2019. PMID: 31575060 Free PMC article.
PRIMAGE project: predictive in silico multiscale analytics to support childhood cancer personalised evaluation empowered by imaging biomarkers.
Martí-Bonmatí L, Alberich-Bayarri Á, Ladenstein R, Blanquer I, Segrelles JD, Cerdá-Alberich L, Gkontra P, Hero B, García-Aznar JM, Keim D, Jentner W, Seymour K, Jiménez-Pastor A, González-Valverde I, Martínez de Las Heras B, Essiaf S, Walker D, Rochette M, Bubak M, Mestres J, Viceconti M, Martí-Besa G, Cañete A, Richmond P, Wertheim KY, Gubala T, Kasztelnik M, Meizner J, Nowakowski P, Gilpérez S, Suárez A, Aznar M, Restante G, Neri E. Martí-Bonmatí L, et al. Among authors: canete a. Eur Radiol Exp. 2020 Apr 3;4(1):22. doi: 10.1186/s41747-020-00150-9. Eur Radiol Exp. 2020. PMID: 32246291 Free PMC article.
Methodological advances in the discovery of novel neuroblastoma therapeutics.
Segura MF, Soriano A, Roma J, Piskareva O, Jiménez C, Boloix A, Fletcher JI, Haber M, Gray JC, Cerdá-Alberich L, Martínez de Las Heras B, Cañete A, Gallego S, Moreno L. Segura MF, et al. Among authors: canete a. Expert Opin Drug Discov. 2022 Feb;17(2):167-179. doi: 10.1080/17460441.2022.2002297. Epub 2021 Nov 22. Expert Opin Drug Discov. 2022. PMID: 34807782 Review.
Suprarenal Masses in Very Young Infants: Is It Safe to Watch and Wait? Report of a SIOPEN Observational Study Results.
Papadakis V, Segura V, Conte M, Plantaz D, Di Cataldo A, Schleiermacher G, Wheeler K, Bermúdez JD, Ash S, Brichard B, Ladenstein R, Combaret V, Sarnacki S, Fagnani AM, Granata C, Cañete A. Papadakis V, et al. Among authors: canete a. Cancers (Basel). 2022 Aug 19;14(16):4007. doi: 10.3390/cancers14164007. Cancers (Basel). 2022. PMID: 36011005 Free PMC article.
Independent Validation of a Deep Learning nnU-Net Tool for Neuroblastoma Detection and Segmentation in MR Images.
Veiga-Canuto D, Cerdà-Alberich L, Jiménez-Pastor A, Carot Sierra JM, Gomis-Maya A, Sangüesa-Nebot C, Fernández-Patón M, Martínez de Las Heras B, Taschner-Mandl S, Düster V, Pötschger U, Simon T, Neri E, Alberich-Bayarri Á, Cañete A, Hero B, Ladenstein R, Martí-Bonmatí L. Veiga-Canuto D, et al. Among authors: canete a. Cancers (Basel). 2023 Mar 6;15(5):1622. doi: 10.3390/cancers15051622. Cancers (Basel). 2023. PMID: 36900410 Free PMC article.
Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience.
Canete A, Gerrard M, Rubie H, Castel V, Di Cataldo A, Munzer C, Ladenstein R, Brichard B, Bermúdez JD, Couturier J, de Bernardi B, Pearson AJ, Michon J. Canete A, et al. J Clin Oncol. 2009 Mar 1;27(7):1014-9. doi: 10.1200/JCO.2007.14.5839. Epub 2009 Jan 26. J Clin Oncol. 2009. PMID: 19171715 Clinical Trial.
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.
Ladenstein R, Pötschger U, Pearson ADJ, Brock P, Luksch R, Castel V, Yaniv I, Papadakis V, Laureys G, Malis J, Balwierz W, Ruud E, Kogner P, Schroeder H, de Lacerda AF, Beck-Popovic M, Bician P, Garami M, Trahair T, Canete A, Ambros PF, Holmes K, Gaze M, Schreier G, Garaventa A, Vassal G, Michon J, Valteau-Couanet D; SIOP Europe Neuroblastoma Group (SIOPEN). Ladenstein R, et al. Among authors: canete a. Lancet Oncol. 2017 Apr;18(4):500-514. doi: 10.1016/S1470-2045(17)30070-0. Epub 2017 Mar 2. Lancet Oncol. 2017. PMID: 28259608 Clinical Trial.
193 results